METHODOLOGY TO IDENTIFY IN-VITRO FERTILIZATION PATIENTS USING A NATIONAL MANAGED CARE DATABASE

Author(s)

Kozma C1, Fincher C2, Hubbard J3, Meletiche DM41Independent Research Consultant/Adjunct Professor, University of South Carolina, St. Helena Island, SC, USA, 2EMD Serono, Inc., Ann Arbor, MI, USA, 3EMD Serono, Inc., San Jose, CA, USA, 4EMD Serono, Inc., Ro

BACKGROUND: The majority of analyses of outcomes related to fertility treatments are conducted in datasets from fertility centers.  To date there has been no established methodology for identifying fertility protocols in payer databases. OBJECTIVES: To identify a methodology for identifying fertility protocols in a national administrative claims database. METHODS: This retrospective descriptive study used PharmMetrics, a national managed care dataset. Patients with at least one prescription for a gonadotropin-releasing hormone agonist (GnRHAg) or antagonist (GnRHAnt) between January 1, 1999 and May 31, 2009 were selected. Drugs billed with a National Drug Code were included and were identified using generic product identifiers.  Index date was set as the first pharmacy claim date for a GnRHAg or GnRHAnt. Patients were excluded if no prescription record for FSH existed in the 7 days pre-index through 60 days post-index and HCG in the 60 day post-index period. Patients must be eligible for services for 12 months before and after the index date, which established continuous eligibility for services. Longer eligibility allows assessment of outcomes such as birth rates. The final sample consisted of patients with an embryo transfer code within 60 days of index. Outcome of delivery codes served as indicators for live birth if they occurred within 294 days (42 weeks) after transfer date. RESULTS: Inclusion and exclusion criteria were applied to patients that had at least one prescription for GnRHAnt or GnRHAg, resulting in some attrition of sample (880 patients with IVF). The 2-year continuous eligibility requirement accounted for the largest number of patients removed.    CONCLUSIONS: Administrative claims data provide a large sample of IVF patients, but are limited in some analyses due to a lack clinical details. The proposed methodology was able to successfully identify IVF treatment cycles and link these to delivery outcomes for treated patients under real-world conditions. 

Conference/Value in Health Info

2011-05, ISPOR 2011, Baltimore, MD, USA

Value in Health, Vol. 14, No. 3 (May 2011)

Code

PIH43

Topic

Real World Data & Information Systems

Topic Subcategory

Health & Insurance Records Systems

Disease

Pediatrics, Reproductive and Sexual Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×